| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Fixed maturities, available for sale, at fair value (net of allowance for credit losses march31, 2026 - 43.9 and december31, 2025 - 36.0 amortized cost march31, 2026 - 26,081.4 and december31, 2025 - 25,776.4) | 23,881,100 | 23,886,800 | 23,405,300 | 23,047,000 |
| Equity securities at fair value | 332,800 | 389,200 | 377,200 | 387,400 |
| Mortgage loans (net of allowance for credit losses march31, 2026 - 17.0 and december31, 2025 - 20.9) | 3,347,800 | 3,256,800 | 3,042,700 | 2,834,300 |
| Policy loans | 141,800 | 140,900 | 141,200 | 137,600 |
| Trading securities | 280,200 | 294,800 | 296,900 | 308,300 |
| Investments held by variable interest entities (net of allowance for credit losses march31, 2026 - 1.0 and december31, 2025 - 0.6 amortized cost march31, 2026 - 292.1 and december31, 2025 - 294.1) | 287,400 | 293,000 | 296,800 | 376,900 |
| Other invested assets | 1,695,100 | 1,737,000 | 1,617,000 | 1,500,500 |
| Total investments | 29,966,200 | 29,998,500 | 29,177,100 | 28,592,000 |
| Cash and cash equivalents - unrestricted | 1,129,500 | 956,100 | 1,218,300 | 766,000 |
| Cash and cash equivalents held by variable interest entities | 24,800 | 27,400 | 23,300 | 50,000 |
| Accrued investment income | 284,200 | 286,000 | 282,000 | 279,400 |
| Present value of future profits | 139,500 | 143,600 | 147,800 | 152,100 |
| Deferred acquisition costs and sales inducements | 2,441,300 | 2,397,300 | 2,343,700 | 2,276,300 |
| Reinsurance receivables (net of allowance for credit losses march31, 2026 - 1.0 and december31, 2025 - 1.0) | 3,611,100 | 3,677,500 | 3,731,700 | 3,753,900 |
| Income tax assets, net | 748,900 | 713,300 | 708,100 | 749,300 |
| Assets held in separate accounts | 2,700 | 2,800 | 2,700 | 2,900 |
| Other assets | 615,200 | 588,100 | 661,500 | 707,200 |
| Total assets | 38,963,400 | 38,790,600 | 38,296,200 | 37,329,100 |
| Policyholder account values, end of period excluding contracts 100 ceded | 18,645,200 | 18,480,500 | 17,872,300 | NaN |
| Policyholder account values, end of period for contracts 100 ceded | 723,000 | 738,500 | 752,400 | NaN |
| Amount of reserves above (below) policyholder account values | -370,900 | -306,400 | -334,400 | NaN |
| Policyholder account balances | 18,997,300 | 18,912,600 | 18,290,300 | 17,609,000 |
| Future policy benefits | 11,722,200 | 11,898,000 | 11,975,500 | 11,787,700 |
| Market risk benefit liability | 58,100 | 48,100 | 52,600 | 63,800 |
| Liability for life insurance policy claims | 58,800 | 58,400 | 61,500 | 60,700 |
| Unearned and advanced premiums | 225,200 | 228,000 | 214,500 | 217,300 |
| Liabilities related to separate accounts | 2,700 | 2,800 | 2,700 | 2,900 |
| Other liabilities | 1,098,600 | 952,800 | 1,036,900 | 935,800 |
| Investment borrowings | 2,691,700 | 2,441,700 | 2,441,700 | 2,441,700 |
| Borrowings related to variable interest entities | 274,400 | 274,400 | 274,300 | 352,800 |
| Notes payable direct corporate obligations | 1,336,000 | 1,335,600 | 1,335,200 | 1,334,700 |
| Total liabilities | 36,465,000 | 36,152,400 | 35,685,200 | 34,806,400 |
| Common stock (0.01 par value, 8,000,000,000 shares authorized, shares issued and outstanding march31, 2026 93,795,306 december31, 2025 94,484,339) | 900 | 900 | 1,000 | 1,000 |
| Additional paid-in capital | 1,277,800 | 1,336,300 | 1,389,400 | 1,441,400 |
| Accumulated other comprehensive loss | -1,217,600 | -1,115,000 | -1,118,900 | -1,252,700 |
| Retained earnings | 2,437,300 | 2,416,000 | 2,339,500 | 2,333,000 |
| Total shareholders' equity | 2,498,400 | 2,638,200 | 2,611,000 | 2,522,700 |
| Total liabilities and shareholders' equity | 38,963,400 | 38,790,600 | 38,296,200 | 37,329,100 |
CNO Financial Group, Inc. (CNO)
CNO Financial Group, Inc. (CNO)